Ayse Serra Ozel

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Men Who Have Sex With Men

Hiv Infected Patients

Induced Apoptosis

Top Venues

AIDS patient care and STDs

This page only lists publications with an associated author ORCID identifier.

Publications

Lütfiye Nilsun Altunal, Dilek Yagcı Caglayık, Ayse Serra Ozel, Elif Tukenmez Tigen, Uluhan Sili, Buket Ertürk Sengel, Mehtap Aydın, Volkan Korten
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS patient care and STDs 37 (3) (2023)
Lütfiye Nilsun Altunal, Dilek Yagcı Caglayık, Ayse Serra Ozel, Elif Tukenmez Tigen, Uluhan Sili, Buket Ertürk Sengel, Mehtap Aydın, Volkan Korten
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS patient care and STDs (2023)
Lütfiye Nilsun Altunal, Dilek Yagcı Caglayık, Ayse Serra Ozel, Elif Tukenmez Tigen, Uluhan Sili, Buket Ertürk Sengel, Mehtap Aydın, Volkan Korten
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS patient care and STDs 37 (3) (2023)
Lütfiye Nilsun Altunal, Dilek Yagcı Caglayık, Ayse Serra Ozel, Elif Tukenmez Tigen, Uluhan Sili, Buket Ertürk Sengel, Mehtap Aydın, Volkan Korten
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS patient care and STDs 37 (3) (2023)
Lütfiye Nilsun Altunal, Dilek Yagcı Caglayık, Ayse Serra Ozel, Elif Tukenmez Tigen, Uluhan Sili, Buket Ertürk Sengel, Mehtap Aydın, Volkan Korten
Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS patient care and STDs 37 (3) (2023)